Gene signalling heterogeneity in exacerbations of COPD determined by microarray analysis of PBMC mRNA Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey Year: 2015
Transcriptome profiling of platelets from patients with severe asthma. Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021
Candidate gene association study of chronic obstructive pulmonary disorder using a targeted high throughput sequencing approach Source: Annual Congress 2012 - Methodology in epidemiologic research Year: 2012
The use of microarray analysis of gene signalling to determine heterogeneity of COPD exacerbation phenotypes Source: ERS Lung Science Conference 2016 Year: 2016
Metagenomic analysis of lower airway microbial diversity in patients with chronic pulmonary disease Source: Annual Congress 2011 - Mechanisms and outcomes of infective exacerbations of COPD Year: 2011
Lipidomic phenotyping of severe asthma Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014
iTRAQ-based proteomic analysis reveals mitochondrial 'damage'-associated molecular patterns are involved in pulmonary inflammation in Lypopolysaccharide-induced acute lung injury Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury Year: 2018
Molecular, metabolic and histological profiling reveal smoke worsens inflammation in a mouse model of viral COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 251s Year: 2005
A whole genome sequencing association study of severe, uncontrolled asthma Source: International Congress 2018 – Multiomics studies in epidemiology: what can they tell us? Year: 2018
The airway ‘resistome’ in chronic respiratory disease: a metagenomics approach Source: International Congress 2019 – The microbiome: novel data across respiratory diseases Year: 2019
Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma Source: Eur Respir J, 50 (3) 1602298; 10.1183/13993003.02298-2016 Year: 2017
COPD phenotypes revealed by the integrated sputum microbiome and proteome analysis in COPDMAP cohort Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019
Transcriptomic and epigenetic changes in the lung of patients with severe COPD Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017
Proteomic and genomic profiling to identify pathogenic mechanisms of inflammation, proteolysis and wasting in a murine COPD model Source: Eur Respir J 2004; 24: Suppl. 48, 104s Year: 2004
RNA-Seq transcriptome profiling of genes regulated by vitamin D in an asthma model Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015
LSC Abstract – Functional metagenomics of respiratoy microbiome in exacerbated COPD Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues Year: 2015
Metabolomic profiling differences among asthma, COPD and healthy controls: a LC-MS-based metabolomics analysis Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019
Microarray gene expression profiling in a murine model of asthma Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008
Differential mast cell activation by transcriptomic signature analysis in the U-BIOPRED severe asthma cohort Source: Virtual Congress 2020 – Novel methods, diagnostics and biomarkers of chronic lung diseases Year: 2020